Corrigendum: combining the smac mimetic lcl161 with gemcitabine plus cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

HIGHLIGHTS

• who: Sunisa Prasopporn et al. from the Frontiers Media SA, SwitzerlandMedicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Department of Pharmacology have published the Article: Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma, in the Journal: (JOURNAL)

SUMMARY

Oncol. 12:1021632. doi: 10.3389/fonc.2022.1021632 In the published article, there was an error in the Funding statement. The correct Funding statement appears below. Frontiers in Oncology frontiersin.org Prasopporn et_al 10.3389/fonc.2022.1124912 The authors apologize for . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.